Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Langrand-Escure

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Revue Medicale De Liege|April 7, 2017
[Atypical presentation of a breast cancer pituitary metastasis]J Langrand-Escure, A Vallard, J-Ph Suchaud, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 6, 2021
[Telemedicine for prostate cancer during long-term radiotherapy follow-up: An opportunity for digital innovation in oncology]L Suc, E Daguenet, S Louati, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 3, 2022
[Securing the information system of health care organisations]B Fleury, P Loudenot, M Suszko, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 5, 2018
Rare histologic types of rectal cancer: A monocentric cases series reportA Vallard, P Diao, M-A Garcia, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2022
[Radiation induced brachial plexopathy: Diagnosis, risk factors, principles of care]C Miran, E Bonnet, C Lafont, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 23, 2021
Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experienceO Ogorodniitchouk, J Aunier, A Bousarsar, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 25, 2016
[Radiotherapy phase I trials' methodology: Features]R Rivoirard, A Vallard, J Langrand-Escure, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 30, 2016
Conflict of interests for radiation oncologists: Harnessing disclosures from policy to realityJ-B Guy, A Vallard, S Espenel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 10, 2018
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendationsJ Langrand-Escure, R de Crevoisier, C Llagostera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 26, 2016
[Hyperbaric oxygen and radiotherapy: From myth to reality]S Espenel, C Raffoux, A Vallard, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Revue Medicale De Liege|April 7, 2017
[Atypical presentation of a breast cancer pituitary metastasis]J Langrand-Escure, A Vallard, J-Ph Suchaud, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 6, 2021
[Telemedicine for prostate cancer during long-term radiotherapy follow-up: An opportunity for digital innovation in oncology]L Suc, E Daguenet, S Louati, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 3, 2022
[Securing the information system of health care organisations]B Fleury, P Loudenot, M Suszko, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 5, 2018
Rare histologic types of rectal cancer: A monocentric cases series reportA Vallard, P Diao, M-A Garcia, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2022
[Radiation induced brachial plexopathy: Diagnosis, risk factors, principles of care]C Miran, E Bonnet, C Lafont, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 23, 2021
Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experienceO Ogorodniitchouk, J Aunier, A Bousarsar, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 25, 2016
[Radiotherapy phase I trials' methodology: Features]R Rivoirard, A Vallard, J Langrand-Escure, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 30, 2016
Conflict of interests for radiation oncologists: Harnessing disclosures from policy to realityJ-B Guy, A Vallard, S Espenel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 10, 2018
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendationsJ Langrand-Escure, R de Crevoisier, C Llagostera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 26, 2016
[Hyperbaric oxygen and radiotherapy: From myth to reality]S Espenel, C Raffoux, A Vallard, et al.
Pageof 2